shareholders. 2. Approval for the determination for authorized directors which shall be effective on 1 June 2020. Details of which are as follows: Current “Mr. Sontiyan Chuenruetainaidhama, Mr. Shine Bunnag, Mr
the Notification, by having obtained an approval from the Capital Market Supervisory Board, to allow exemption for some kinds of intermediary not to comply with any requirement under this Notification
there is any progress, the Company shall further inform the shareholders. 2. Approval for the determination of authorized directors who sign to bind the Company, which shall be effective from 1 June 2020
Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of
Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment of an Executive of a Derivatives Business
and Exchange Commission Notification of the Office of the Securities and Exchange Commission No. OrThor/Nor/Khor. 11/2548 Re: Practical Guideline on Application for Approval and Approval for Appointment
securities business, having obtained an approval to establish from and having registered [such establishment] with the SEC Office; (2) an association relating to supervision of a derivatives intermediary, of
Procedures for Approval of the Private Fund Custodian 22/12/2004 16/12/2004 4. Notification of Capital Market Supervisory Board 85/2552 03/08/2009 01/09/2009 5. Notification of Capital Market
accounting and approval of the disposal of investmentsBS Myco Biotech Company Limited ( 2 st review) 28/12/2021 19:33 Notification of the resignation of the Company's director and appointment of a supervisor
(effective on 1 January 2018). 2 “association” means: (1) an association relating to a securities business, of which objectives is for promoting and developing securities business, having obtained an approval